Clinical trials
Biopsy clinical trials
Below are recruiting biopsy clinical trials, each written for real people, not researchers. We’re tracking 937 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07358715Recruiting
Liquid biopsy to improve lung cancer screening
This study tests whether a simple blood test (liquid biopsy) can help find lung cancer earlier in people at high risk. It also includes people already diagnosed with lung cancer to refine the test.
SingaporeAges 21–75 - NCT06853834Recruiting
Comparing two biopsy methods for suspected sarcoidosis
This trial compares two ways of taking a lung tissue sample (cryo biopsy vs forceps biopsy) in people who may have sarcoidosis. The goal is to see which method is better at diagnosing the condition.
Lucknow, Uttar PradeshAges 18 years+ - NCT06306118Recruiting
Guiding device for more precise brain biopsies
This trial tests a new positioning device that helps doctors take small tissue samples (biopsies) from brain lesions more precisely during surgery. If you have a brain lesion that needs to be removed, this study may help improve accuracy.
Graz, StyriaAges 18–80 - NCT05470127Recruiting
Testing a new prostate biopsy needle against the usual one
This study compares a new prostate biopsy system/needle with the standard biopsy needle during your scheduled prostate biopsy. It looks at how well the procedure collects tissue for diagnosis and how the tissue samples compare.
Cartersville, GeorgiaAges 18–90 - NCT06841211Recruiting
Optimizing prostate biopsy for multiple MRI lesions
This study aims to find the best way to take tissue samples (biopsies) from the prostate when MRI shows more than one suspicious spot. It will help doctors know exactly where to biopsy to reduce false negatives and avoid missing cancer.
Beijing, Beijing MunicipalityAges 18–85 - NCT05810402Recruiting
Testing immunotherapy for advanced liver cancer using blood tests
This study looks at how well immune-checkpoint therapy (a PD-1 or PD-L1 immunotherapy) works for advanced liver cancer, using “liquid biopsy” blood testing to guide or monitor care. It may help your team better track your cancer and response without needing repeated tissue biopsies.
MontpellierAges 18 years+ - NCT06287749Recruiting
Liquid biopsy for monitoring pancreatic cancer after surgery
This trial is testing a blood test (liquid biopsy) to look for tiny traces of cancer DNA after surgery for pancreatic cancer. It may help doctors understand if the cancer is likely to come back.
Montpellier, HéraultAges 18 years+ - NCT06830265Recruiting
Comparing a new biopsy needle to the standard one for prostate cancer
This study tests a new, specially designed biopsy needle system against the standard needle system used for prostate biopsies. The researchers will compare how well each system collects tissue samples from men who have suspicious MRI findings, to see if the new needle might give better results.
New York, New YorkAges 18 years+ - NCT06824402Recruiting
Cryoprobe Biopsy for Chronic Rejection in Lung Transplant
This trial tests a new biopsy method called cryoprobe (using a cold probe) to better detect chronic rejection in lung transplant patients. It is for patients who already need a lung biopsy, either for routine monitoring or because of a concern.
Rochester, MinnesotaAges 18–99 - NCT06611072Recruiting
Boosting immune response in ovarian cancer surgery
This study examines how to improve the immune system's response during ovarian cancer surgery, potentially helping the body fight the cancer better. It compares patients with ovarian cancer to women having surgery for non-cancerous conditions.
Eindhoven, North BrabantAges 18 years+ - NCT06579911Recruiting
Micro-ultrasound vs. MRI for prostate biopsy
This trial compares two advanced imaging techniques—high-frequency micro-ultrasound and multiparametric MRI—to guide biopsies for men who may have aggressive prostate cancer. The goal is to see which method better detects cancer while reducing unnecessary biopsies.
Salzburg, State of SalzburgAges 18–99 - NCT06517901Recruiting
Comparing two MRI-guided biopsy methods for prostate cancer
This trial compares two ways to use MRI images during a prostate biopsy to see which finds cancer better. It looks at 'fusion' biopsy (where a computer combines MRI with live ultrasound) versus 'cognitive' biopsy (where the doctor mentally matches the MRI to the ultrasound).
Burlington, MassachusettsAges 18 years+ - NCT06340178Recruiting
CT-guided lung biopsy risk reduction study
This trial uses a new method to make CT-guided lung biopsies safer. It may reduce complications for patients who need a lung biopsy for an unclear or suspicious spot.
BernAges 18–100 - NCT06287814Recruiting
Blood test to detect leftover cancer DNA in colorectal cancer patients
This study uses a simple blood test (liquid biopsy) to look for tiny bits of tumor DNA remaining after colorectal cancer surgery. It aims to see if the test can help predict whether the cancer will come back, especially in people with stage III cancer who will receive chemotherapy.
Montpellier, HéraultAges 18 years+ - NCT06287723Recruiting
Blood test for cancer DNA after liver surgery in colorectal cancer
This study uses a simple blood test (liquid biopsy) to look for tiny bits of cancer DNA after surgery for colorectal cancer that spread to the liver. It aims to see if this test can find cancer earlier than standard scans, which may help guide future treatment decisions.
MontpellierAges 18 years+ - NCT05774561Recruiting
Using blood tests to monitor HPV-related cancer treatment
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
OlomoucAges 18–99 - NCT07870265Recruiting
Blood test for detecting BRAF mutation in melanoma
This trial tests a new blood test to detect a specific gene change (BRAF V600E) in melanoma that has come back. The test uses a technology called CRISPR to find the mutation in a simple blood draw, which could help guide treatment without needing a tissue biopsy.
Brno, BrnoAges 18 years+ - NCT03250091Recruiting
Stomach precancer check-up study after scope
This study follows people who have had an upper endoscopy (a camera test through the mouth to look at the stomach) to monitor precancerous stomach changes. It may help doctors learn the best way to watch these spots over time and catch problems early.
RigaAges 18 years+ - NCT01194648Recruiting
HIFU treatment for early prostate cancer
This trial studies a focused ultrasound treatment called HIFU for prostate cancer that appears limited to the early stages. It aims to treat cancer within the prostate while avoiding treatment spread to lymph nodes or distant organs.
London, EnglandAges Up to 90 years - NCT05408897Recruiting
Blood test to predict risk after surgery for high-risk GIST
This study uses a “liquid biopsy” blood test to look for leftover cancer signals after surgery. It aims to predict how well treatment will work and how likely the cancer is to come back in people with high-risk GIST.
Beijing, Beijing MunicipalityAges Any age - NCT04743102Recruiting
Multi-point full-thickness biopsy to confirm complete rectal cancer response
This trial checks whether taking small samples from the full thickness of rectal tissue can accurately confirm that rectal cancer has fully responded to chemotherapy and/or radiation. It may help doctors decide the best next step if no tumor is seen after treatment.
Beijing, Beijing MunicipalityAges 18–80 - NCT05316103Recruiting
Optical biopsy of rectal scars after cancer treatment
This trial tests a targeted “optical biopsy” (using a special light-based exam to sample tissue) to better assess rectal scars after standard chemotherapy and radiation before surgery. It may help surgeons choose the most appropriate way to operate on rectal cancer.
Guangzhou, GuangdongAges 18–80 - NCT06074822Recruiting
Biobank study for neuromuscular disease samples
This study collects leftover tissue from muscle or nerve biopsies to build a biobank for future research on neuromuscular diseases. It may help improve diagnosis and treatment for conditions like yours.
BordeauxAges Any age - NCT05048862Recruiting
Brain scan and tests for neuromuscular conditions
This study compares people with neuromuscular disorders to healthy people using questionnaires and brain/neurological tests. It may help researchers understand how these conditions affect the brain and nervous system.
TaipeiAges 20 years+
Hear when a new Biopsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for biopsy?
- Yes. Clin2 currently lists 937 recruiting biopsy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biopsy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biopsy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.